Companies / REGN vs JNJ
REGN vs JNJ: Regeneron Pharmaceuticals and Johnson & Johnson
Regeneron Pharmaceuticals (REGN) reported $14.3B in revenue against a 31.4% net margin, while Johnson & Johnson (JNJ) reported $94.2B at a 28.5% net margin, most recently.
| Metric | REGN | JNJ |
|---|---|---|
| Revenue | $14.3B | $94.2B |
| Net Income | $4.5B | $26.8B |
| Gross Margin | — | 67.9% |
| Operating Margin | 24.9% | — |
| EPS (Diluted) | $41.48 | $11.03 |
| Free Cash Flow | $4.1B | $19.7B |
| Total Debt | $2.7B | $49.9B |
| P/E Ratio | 18.6× | 18.8× |
| P/B Ratio | n/m | n/m |
| Stock Price | $910.75 | $272.48 |
Free: last 5 years
| Fiscal year | FY2008 🔒 | FY2010 🔒 | FY2011 🔒 | FY2012 🔒 | FY2013 🔒 | FY2014 🔒 | FY2016 🔒 | FY2017 🔒 | FY2018 🔒 | FY2019 🔒 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REGN Revenue | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $16.1B | $12.2B | $13.1B | $14.2B | $14.3B |
| JNJ Revenue | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $82.6B | $78.7B | $85.2B | $88.8B | $94.2B |